Paul C. de Jong

665 total citations
19 papers, 448 citations indexed

About

Paul C. de Jong is a scholar working on Oncology, Genetics and Electrical and Electronic Engineering. According to data from OpenAlex, Paul C. de Jong has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Genetics and 4 papers in Electrical and Electronic Engineering. Recurrent topics in Paul C. de Jong's work include Estrogen and related hormone effects (5 papers), Sensor Technology and Measurement Systems (3 papers) and Cancer Treatment and Pharmacology (3 papers). Paul C. de Jong is often cited by papers focused on Estrogen and related hormone effects (5 papers), Sensor Technology and Measurement Systems (3 papers) and Cancer Treatment and Pharmacology (3 papers). Paul C. de Jong collaborates with scholars based in Netherlands, Sweden and United States. Paul C. de Jong's co-authors include Martin van den Berg, Rocío F. Cantón, Göran Marsh, G.C.M. Meijer, Majorie B.M. van Duursen, Ellen S. de Morrée, Sandra M. Nijmeijer, Marinus A. Blankenstein, J.H.H. Thijssen and J. van de Ven and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Paul C. de Jong

19 papers receiving 436 citations

Peers

Countries citing papers authored by Paul C. de Jong

Since Specialization

Citations

This map shows the geographic impact of Paul C. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul C. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul C. de Jong more than expected).

Fields of papers citing papers by Paul C. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul C. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul C. de Jong. The network helps show where Paul C. de Jong may publish in the future.

Co-authorship network of co-authors of Paul C. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Paul C. de Jong. A scholar is included among the top collaborators of Paul C. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul C. de Jong. Paul C. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC). 2023 ·Journal of Clinical Oncology ·Gabe S. Sonke, (unknown), (unknown), Vincent van der Noort, Astrid C P Swinkels, Hedwig M. Blommestein, Aart Beeker, Karin Beelen, (unknown), Joan B. Heijns, Aafke H. Honkoop, Paul C. de Jong, (unknown), (unknown), Jolien Tol, (unknown), Suzan Vrijaldenhoven, A. Elise van Leeuwen‐Stok, Inge R. Konings, Agnes Jager	55
2	The effect of trastuzumab on cardiac function in patients with HER2‐positive metastatic breast cancer and reduced baseline left ventricular ejection fraction 2022 ·International Journal of Cancer ·(unknown), Tessa G. Steenbruggen, Hánah N. Rier, Jos Kitzen, Carolien H. Smorenburg, (unknown), Paul C. de Jong, Jan C. Drooger, Cynthia Holterhues, Marcel J.M. Kofflard, Eric Boersma, Gabe S. Sonke, Mark‐David Levin, Agnes Jager	5
3	Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane 2021 ·International Immunopharmacology ·Annelieke E.C.A.B. Willemsen, Xuehui He, Bram van Cranenbroek, Paul C. de Jong, Maaike de Boer, Irma Joosten, Hans J. P. M. Koenen, Carla M.L. van Herpen, Winald R. Gerritsen	3
4	Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane 2019 ·Targeted Oncology ·Annelieke E.C.A.B. Willemsen, Jolien Tol, Nielka P. van Erp, Marianne A. Jonker, Maaike de Boer, Bob Meek, Paul C. de Jong, (unknown), Winald R. Gerritsen, Jan C. Grutters, Carla M.L. van Herpen	10
5	Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane 2018 ·Targeted Oncology ·Annelieke E.C.A.B. Willemsen, Lioe‐Fee de Geus‐Oei, Maaike de Boer, Jolien Tol, Y.J.L. Kamm, Paul C. de Jong, Marianne A. Jonker, Allert H. Vos, Willem Grootjans, (unknown), Sasja F. Mulder, Erik H.J.G. Aarntzen, Winald R. Gerritsen, Carla M.L. van Herpen, Nielka P. van Erp	9
6	Everolimus exposure and early metabolic response as predictors for treatment outcomes in breast cancer patients treated with everolimus and exemestane. 2018 ·Journal of Clinical Oncology ·Annelieke E.C.A.B. Willemsen, Lioe‐Fee de Geus‐Oei, Maaike de Boer, Jolien Tol, Y.J.L. Kamm, Paul C. de Jong, Allert H. Vos, Jan Willem de Groot, Sasja F. Mulder, Erik H.J.G. Aarntzen, Winald R. Gerritsen, Carla M.L. van Herpen, Nielka P. van Erp	2
7	[Risks associated with phytoestrogen dietary supplementation and adjuvant hormonal therapy for breast cancer]. 2013 ·PubMed ·(unknown), Irene van den Broek, Paul C. de Jong, Martin van den Berg	2
8	Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model 2011 ·Toxicology ·Majorie B.M. van Duursen, Sandra M. Nijmeijer, Ellen S. de Morrée, Paul C. de Jong, Martin van den Berg	61
9	Non-destructive testing of crystalline silicon photovoltaic back-contact modules 2011 ·Energy Procedia ·Dirk Veldman, (unknown), (unknown), Paul C. de Jong	9
10	Inhibition of human placental aromatase activity by hydroxylated polybrominated diphenyl ethers (OH-PBDEs) 2007 ·Toxicology and Applied Pharmacology ·Rocío F. Cantón, (unknown), Göran Marsh, Paul C. de Jong, Martin van den Berg	130
11	Inhibition of aromatase activity by methyl sulfonyl PCB metabolites in primary culture of human mammary fibroblasts 2004 ·Toxicology and Applied Pharmacology ·Marjoke Heneweer, Martin van den Berg, (unknown), Paul C. de Jong, Åke Bergman, J. Thomas Sanderson	17
12	The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease 2003 ·The Journal of Steroid Biochemistry and Molecular Biology ·Paul C. de Jong, Marinus A. Blankenstein, J.W.R. Nortier, P. H. Th. J. Slee, (unknown), (unknown), (unknown), (unknown), Geert H. Blijham, Jos H.H. Thijssen, Qing Lü, Danijela Jelovac, Angela Brodie	13
13	Some Unusual Paraneoplastic Syndromes 2003 ·Journal of Clinical Oncology ·(unknown), (unknown), Paul C. de Jong, Anneke M. Westermann	3
14	Importance of local aromatase activity in hormone-dependent breast cancer: a review 2001 ·The Breast ·Paul C. de Jong, Marinus A. Blankenstein, J. van de Ven, J.W.R. Nortier, G.H. Blijham, J.H.H. Thijssen	26
15	Integrated Interfaces for Low-Cost Multiple-Sensor Systems 1999 ·Journal of Intelligent Material Systems and Structures ·G.C.M. Meijer, Frank M. L. van der Goes, Paul C. de Jong, Xiujun Li, (unknown)	2
16	<title>High-temperature pressure transducer interface</title> 1998 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Paul C. de Jong, G.C.M. Meijer	3
17	Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole 1997 ·European Journal of Cancer ·Paul C. de Jong, J. van de Ven, J. W. R. Nortier, (unknown), (unknown), J.H.H. Thijssen, (unknown), Marinus A. Blankenstein	46
18	Dithering of First-Order Sigma-Delta Modulators 1994 ·European Solid-State Circuits Conference ·Paul C. de Jong, G.C.M. Meijer, Arthur van Roermund	1
19	New concepts for smart signal processors and their application to PSD displacement transducers 1992 ·Sensors and Actuators A Physical ·G.C.M. Meijer, (unknown), Paul C. de Jong, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact